Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, with both terms appearing during the transition.SummaryDifference1%

- Check20 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check27 days agoChange DetectedThe ClinicalTrials.gov error page now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details. As a result, access to the trial information and related links is removed from the page.SummaryDifference19%

- Check69 days agoChange DetectedThe page shows revision v3.6.6, replacing v3.6.5. This indicates an update to the site's version or content rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.